MedPath

COVID Breath Test - Ancon

Completed
Conditions
Covid19
Interventions
Diagnostic Test: Breath test
Registration Number
NCT04760639
Lead Sponsor
Medical University of South Carolina
Brief Summary

This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age 18 years and older
  • Patients that present for COVID-19 testing, have tested Covid negative, or Covid Positive patients.
Exclusion Criteria
  • Unable to consent
  • Patients on a ventilator
  • Pregnant Women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Test groupBreath testParticipants who have a positive Covid-19 Test or negative Covid-19 test who provide a breath sample.
Primary Outcome Measures
NameTimeMethod
Provide an adequate sample and compare the signals given from the two groups.10 minutes

The samples from the participants will be analyzed to identify the different signals given from Covid-19 positive patients and Covid-19 negative patients

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath